Topic: pneumococcal vaccine
Racing to the market with rival Merck, Pfizer won an important FDA "breakthrough" tag for its next-gen pneumococcal vaccine candidate.
Merck is already in phase 3 testing for its next-generation pneumococcal vaccine, and Pfizer's CFO said his company is "all in" on advancing its shot.
Looking to take on global vaccine heavyweights, SutroVax revs up with Series C funding and a prominent new chairman.
Pfizer has three vaccine programs in development—and top executives have high hopes—but two key programs have competitors close behind.
Serum Institute of India plans to launch four vaccines in the coming years for pneumococcal, HPV, meningococcal and dengue.
Pfizer has relaunched its “Know Pneumonia” disease awareness campaign with a myths-and-facts approach.
Pfizer taps singer Patti LaBelle to raise awareness about risks of pneumococcal pneumonia for older adults in online campaign "All About Your Boom."
MSF's strong opposition didn't stop India's government from granting Pfizer a patent that protects Prevnar's exclusivity till 2026.